The Problem Despite advances in digitizing supply chain management and making data-driven decisions, business planners and executives still expend significant time and effort on understanding ...

The FDC released a second highly critical report of PBMs, which may provide further impetus for legislative action to curb ...

The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...

For the second time in less than a year, the FTC has released a highly critical report of pharmacy benefit managers, or PBMs.

CVS Caremark, Express Scripts and OptumRx dramatically mark up specialty generic drugs to affiliated pharmacies, the Federal ...

The pharmaceutical supply chain is a sector infamous for glacially slow adjustments, lackluster reform, lack of transparency ...

At issue is the role pharmacy benefit mangers play in taking large discounts on drugs that advocates say are not passed along ...

It's the latest in a series of lawsuits against Express Scripts and Optum, as pharmacy benefit managers begin to come under more scrutiny.

Group argues the law interferes with plan benefit design Case is part of a series of challenges to state PBM laws A Minnesota law imposing restrictions on pharmacy benefit managers interferes with ...

Even though pharmacy benefit manager (PBM) reforms were dropped from the continuing ... which serve as middlemen in the nation’s drug supply chain.

With the final bill, pharmacy benefit managers, companies that sit in between payers and pharmaceutical companies in the drug supply chain ... However, it’s likely PBM reform will be ...

Ron Wyden says Elon Musk, an advisor to President Donald Trump who's on track to lead a new Department of Government Efficiency, pushed the PBM provisions out of the package. The new American ...